Safety, Ethics and Regulations
Open accessThe DOI matches its Crossref record.
Abstract
This invaluable resource discusses the saftey, ethics, and regulations of developing stem cell clinical applications. Each chapter is contributed by a preeminent scientist in the field and covers such topics as clinical safety of stem cell gene therapy, the patentability of hESC technologies, international guidelines, challenges to international stem cell clinical trials, worldwide regulations including in emerging markets like China and India. Saftey, Ethics, and Regulations and the other books in the Stem Cells in Clinical Applications series will be invaluable to scientists, researchers, advanced students and clinicians working in stem cells, regenerative medicine or tissue engineering. The book: - Addresses some of the most crucial safety challenges of clinical stem cell applications - Provides up-to-date insights on recent regulatory developments in the stem cell fields - Examines key ethical issues of the clinical translation process in different socio-economic, regulatory and healthcare contexts - Discusses the challenges of regulatory variation and ethical pluralism for international clinical research collaborations
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a study involving 226 patients who received human platelet lysate (hPL)-expanded MSCs for their orthopedic conditions, no malignant transformation was observed during a mean follow-up of 11 months [41,42].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [41]
In the citing paper
“Interestingly, chromosomal abnormalities in culture-expanded MSCs appear to be linked to cell senescence due to extensive passaging, rather than tumorigenesis [41,43,44].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [41]
In the citing paper
“Similarly, Tarte et al. (2010) found that clinical-grade MSCs production, which displayed some chromosomal instability, did not impact their transformation potential both in vitro and in vivo [41,43].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [41]
In the citing paper
“Various studies have shown that MSCs’ transplantation/infusion in humans is a safe procedure, showing no indications of malignant alterations [41].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [41]
Citations
Cites
Still being checked.
Cited by
Baron, M., Drohat, P., Crawford, B., Hornicek, F. J., Best, T. M., & Kouroupis, D. (2023) · Bioengineering · doi:10.3390/bioengineering10101187 · Cited by 19
Synthetic embryos: a new venue in ethical research
Villalba, A., Rueda, J., & Beriaín, Í. D. M. (2023) · Reproduction · doi:10.1530/rep-22-0416 · Cited by 10
Jones, M., Jones, E., & Kouroupis, D. (2024) · Bioengineering · doi:10.3390/bioengineering11100961 · Cited by 13
Ethical Considerations in Stem Cell Therapeutics
Kumar, R., Madan, A., Mitra, D., & Chandravanshi, J. S. (2025) · doi:10.1002/9781394313785.ch18 · Cited by 6
Metadata
- Authors
- Pham, P. V., & Pham, P. V.
- Affiliations
- Vietnam National University Ho Chi Minh City (VN)
- University of Warwick (GB)
- Venue
- Stem Cells in Clinical Applications
- Publisher
- Springer International Publishing
- Published
- 2017
- ISSN
- 2365-4198 (ISSN-L)
- 2365-4201
- OpenAlex
- W2591712668
- Cited by
- 4
- References
- 0
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 2
- FWCI
- 0.00
- Type
- book
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- www.springer.com/tdm (tdm)
- Locations
- Stem cells in clinical applications (publishedVersion)
- DIAL (Catholic University of Leuven) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Springer eBooks
- Topics
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- Keywords
- clinical safety, stem cell gene therapy, human embryonic stem cells, patentability, international guidelines, stem cell clinical trials, stem cell regulation, emerging markets, China, India, moral pluralism, clinical translation, regenerative medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Safety, Ethics and Regulations. https://app.cochat.ai/papers/10.1007/978-3-319-59165-0
- The paper
- Pham, P. V., & Pham, P. V. (2017). Safety, Ethics and Regulations. Stem Cells in Clinical Applications. https://doi.org/10.1007/978-3-319-59165-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.